EUVIMEDSkopri EUVIMED
Randomisierte kontrollierte StudieMultizentrische StudieOpen access · CC BY-NC 4.0

A multicenter randomized, double‐blind, placebo‐controlled, parallel‐group study to evaluate the effects of a 1‐year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well‐controlled asthma

Philippe Bareille iD, Varsha Imber iD, Jodie Crawford, Bernadetta Majorek-Olechowska, Zeina Karam-Absi, Sally Stone, Ruby Birk

Pediatric Pulmonology · 2023

DOI: 10.1002/ppul.26679 ↗

At a glance

Randomisierte kontrollierte Studie in Pediatric Pulmonology, 2023. Written by Philippe Bareille and 6 co-authors. Institution: GSK, Stevenage, UK. Major MEDLINE topics: Bronchodilator Agents, Asthma. Cited 2 times so far (Crossref); 29 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: GSK.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Introduction : Growth impairment is a known adverse event (AE) of corticosteroids in children. This study aimed to assess the effect of once‐daily (QD) inhaled fluticasone furoate (FF) versus placebo on growth velocity over 1 year in prepubertal children with well‐controlled asthma. Materials and Methods : This randomized, double‐blind, parallel‐group, placebo‐controlled, multicenter study (NCT02889809) included prepubertal children, aged 5 to

Subjects

MeSH terms (MEDLINE)

Bronchodilator AgentsAsthmaFemaleHumansChildMaleAdministration, InhalationDouble-Blind MethodTreatment OutcomeFluticasoneAcetatesCyclopropanesQuinolinesSulfidesAndrostadienes

Author keywords

heightinhaled corticosteroidspediatric asthma

Substances

Bronchodilator AgentsFluticasonemontelukastAcetatesCyclopropanesQuinolinesSulfidesfluticasone furoateAndrostadienes

Authors and institutions

  • GSK, Stevenage, UK.
  • GSK, Brentford, London, UK.
  • Alergo-Med Specialist Medical Clinic, Tarnów, Poland.
  • Parexel International, Paris, France.

ORCID profiles: Philippe Bareille, Varsha Imber

Funding

  • GSK

Cite

APA

Bareille, P., Imber, V., Crawford, J., Majorek-Olechowska, B., Karam-Absi, Z., Stone, S., & Birk, R. (2023). A multicenter randomized, double‐blind, placebo‐controlled, parallel‐group study to evaluate the effects of a 1‐year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well‐controlled asthma. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26679

Vancouver

Bareille P, Imber V, Crawford J, Majorek-Olechowska B, Karam-Absi Z, Stone S, et al. A multicenter randomized, double‐blind, placebo‐controlled, parallel‐group study to evaluate the effects of a 1‐year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well‐controlled asthma. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26679

BibTeX
@article{Bareille2023,
  author = {Bareille, Philippe and Imber, Varsha and Crawford, Jodie and Majorek-Olechowska, Bernadetta and Karam-Absi, Zeina and Stone, Sally and Birk, Ruby},
  title = {A multicenter randomized, double‐blind, placebo‐controlled, parallel‐group study to evaluate the effects of a 1‐year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well‐controlled asthma},
  journal = {Pediatric Pulmonology},
  year = {2023},
  doi = {10.1002/ppul.26679}
}
Start for free →